Sphera Funds Management Ltd. has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $380 Million distributed in 116 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Teva Pharmaceutical Industries LTD with a value of $24.2M, Syndax Pharmaceuticals Inc with a value of $20.5M, Sanofi with a value of $16.9M, Nova Ltd. with a value of $16.7M, and Astrazeneca PLC with a value of $12.9M.
Examining the 13F form we can see an decrease of $106M in the current position value, from $486M to 380M.
Sphera Funds Management Ltd. is based out at Tel Aviv, L3
Below you can find more details about Sphera Funds Management Ltd. portfolio as well as his latest detailed transactions.